“…[718][719][720][721][722] TGF-β-mediated immunosuppression can also contribute to viral infection, as elevated TGF-β expression during viral infection not only impairs early innate immunity such as IFN responses, NK functions, and macrophage activity but also suppresses the adaptive immune responses of T cells and B cells. 428,[723][724][725][726][727][728][729][730][731] Notably, TGF-β can also enhance viral infection through certain pathogen-specific mechanisms as in the cases of human immunodeficiency virus type 1 (HIV-1) infection, [732][733][734] human T-cell leukemia virus type I (HTLV-I) infection, 735 hepatitis C virus (HCV) infection, 736 Zika virus (ZIKV) infection, 737 as well as rubella virus (RuV) infection. 738 Furthermore, TGF-β can promote the survival and growth of parasites in hosts through downregulation of NO, IFN-γ, TNF-α, IL-6, IL-17, and Th17 cells as well as upregulation of IL-4, IL-10, and Treg cells, contributing to the infection of Fasciola hepatica, 739 Echinococcus multilocularis, 740 Toxoplasma gondii, 741 Leishmania, 742 and Plasmodium.…”